Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experimental studies on combination chemotherapy based on cell cycle analysis].

T Tsuboi

    Nihon Sanka Fujinka Gakkai Zasshi
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neuroimaging Advances in Deep Brain Stimulation: Review of Indications, Anatomy, and Brain Connectomics.

    AJNR. American journal of neuroradiology·2020
    Same author

    Functional and Structural Connectivity Patterns Associated with Clinical Outcomes in Deep Brain Stimulation of the Globus Pallidus Internus for Generalized Dystonia.

    AJNR. American journal of neuroradiology·2020
    Same author

    Comprehensive and quantitative assessment of nitrate dynamics in two contrasting forested basins along the Sea of Japan using dual isotopes of nitrate.

    The Science of the total environment·2019
    Same author

    3-O-Laurylglyceryl ascorbate reinforces skin barrier function through not only the reduction of oxidative stress but also the activation of ceramide synthesis.

    International journal of cosmetic science·2016
    Same author

    Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study.

    Pharmacopsychiatry·2015
    Same author

    Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.

    Scientific reports·2015
    Same journal

    [A case of fibrosarcoma of the ovary].

    Nihon Sanka Fujinka Gakkai zasshi·1996
    Same journal

    [Ovarian cancer with prior gynecological laparotomy].

    Nihon Sanka Fujinka Gakkai zasshi·1996
    Same journal

    [Clinical and histopathologic features of the uterine lipoleiomyoma].

    Nihon Sanka Fujinka Gakkai zasshi·1996
    Same journal

    [A case of peritonitis with systemic lupus erythematosus].

    Nihon Sanka Fujinka Gakkai zasshi·1996
    Same journal

    Attempt to continue pregnancy of remaining fetuses after delivery of preceding fetus in multiple pregnancies before 24 weeks gestation: report of three cases.

    Nihon Sanka Fujinka Gakkai zasshi·1996
    Same journal

    [Findings of uterine sarcoma and uterine myoma by color and power Doppler].

    Nihon Sanka Fujinka Gakkai zasshi·1996
    See all related articles

    Peplomycin alters cell cycle distribution, increasing cells in S and G2-M phases. Optimal combination chemotherapy with peplomycin involves timing drug administration with cell cycle synchronization for enhanced efficacy.

    Area of Science:

    • Cell Biology
    • Pharmacology
    • Oncology

    Context:

    • Peplomycin (PEP) is an antineoplastic agent used in cancer treatment.
    • Understanding drug-induced cell cycle perturbations is crucial for optimizing chemotherapy regimens.
    • HeLa S-3 and SNG-M cell lines provide models for studying drug effects on cell proliferation.

    Purpose:

    • To investigate the effects of Peplomycin on cell cycle distribution in vitro.
    • To determine optimal timing and drug combinations for Peplomycin-based chemotherapy.
    • To evaluate the cytotoxic potency of various chemotherapeutic agents in combination with Peplomycin.

    Summary:

    • Peplomycin treatment induced a redistribution of cells, decreasing G1 phase populations and increasing S and G2-M phase populations.

    Related Experiment Videos

  • Maximum accumulation in S phase occurred at 12 hours (HeLa S-3) and 16 hours (SNG-M), while G2-M phase accumulation peaked at 16 hours (HeLa S-3) and 22 hours (SNG-M).
  • Combination studies indicated that Cis-DDP and 4-hydroperoxy cyclophosphamide were most effective with Peplomycin, particularly when administered during the G2-M phase synchronization.

    • Impact:

    • Findings suggest that combination chemotherapy efficacy is enhanced by synchronizing drug administration with Peplomycin-induced G2-M phase arrest.
    • This research provides a basis for developing more effective, cell cycle-based combination chemotherapy strategies.
    • Optimizing chemotherapy timing based on cell cycle analysis can improve treatment outcomes and reduce toxicity.